80 FR 50300 - National Center for Advancing Translational Sciences: Notice of Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 160 (August 19, 2015)

Page Range		50300-50300
FR Document		2015-20450

Federal Register, Volume 80 Issue 160 (Wednesday, August 19, 2015)

[Federal Register Volume 80, Number 160 (Wednesday, August 19, 2015)]
[Notices]
[Page 50300]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-20450]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences: Notice of 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of meetings of the 
National Center for Advancing Translational Sciences Advisory Council.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Cures Acceleration Network Review Board.
    Date: September 3, 2015.
    Time: 8 a.m. to 3:15 p.m.
    Agenda: Report from the Institute Director.
    Place: National Institutes of Health, Building 31, Conference 
Room 6, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Danilo A. Tagle, Ph.D., Executive Secretary, 
National Center for Advancing Translational Sciences, 1 Democracy 
Plaza, Room 992, Bethesda, MD 20892, 301-594-8064, 
[email protected].

    This notice is being published less than 15 days prior to the 
meeting due to finalizing the agenda and scheduling of meeting 
topics.

    Name of Committee: National Center for Advancing Translational 
Sciences Advisory Council.
    Date: September 3, 2015.
    Open: 8 a.m. to 3:15 p.m.
    Agenda: Report from the Institute Director and other staff.
    Place: National Institutes of Health, Building 31, Conference 
Room 6, 31 Center Drive, Bethesda, MD 20892.
    Closed: 3:30 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications
    Place: National Institutes of Health, Building 31, Conference 
Room 6, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Danilo A. Tagle, Ph.D., Executive Secretary, 
National Center for Advancing Translational Sciences, 1 Democracy 
Plaza, Room 992, Bethesda, MD 20892, 301-594-8064, 
[email protected].

    This notice is being published less than 15 days prior to the 
meeting due to finalizing the agenda and scheduling of meeting 
topics.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: August 13, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-20450 Filed 8-18-15; 8:45 am]
BILLING CODE 4140-01-P

50300 Federal Register / Vol. 80, No. 160 / Wednesday, August 19, 2015 / Notices

notify the Contact Person listed below Repayment Program; 93.187, Undergraduate Agenda: Report from the Institute Director
in advance of the meeting. Scholarship Program for Individuals from and other staff.
Disadvantaged Backgrounds, National Place: National Institutes of Health,
Name of Committee: Recombinant DNA Institutes of Health, HHS) Building 31, Conference Room 6, 31 Center
Advisory Committee. Drive, Bethesda, MD 20892.
Date: September 9, 2015. Dated: August 13, 2015.
Closed: 3:30 p.m. to 5 p.m.
Time: 10:15 a.m. to 5 p.m. Carolyn Baum, Agenda: To review and evaluate grant
Agenda: The NIH Recombinant DNA Program Analyst, Office of Federal Advisory applications
Advisory Committee (RAC) will review and Committee Policy. Place: National Institutes of Health,
discuss selected human gene transfer Building 31, Conference Room 6, 31 Center
[FR Doc. 2015–20448 Filed 8–18–15; 8:45 am]
protocols and related data management Drive, Bethesda, MD 20892.
activities. For more information please check BILLING CODE 4140–01–P
Contact Person: Danilo A. Tagle, Ph.D.,
the meeting agenda at OBA Meetings Page Executive Secretary, National Center for
(available at the following URL: https:// Advancing Translational Sciences, 1
auth.osp.od.nih.gov/office-biotechnology- DEPARTMENT OF HEALTH AND Democracy Plaza, Room 992, Bethesda, MD
activities/event/2015-09-09-120000-2015-09- HUMAN SERVICES 20892, 301–594–8064, Danilo.Tagle@nih.gov.
09-210000/rac-meeting.
This notice is being published less than 15
Place: National Institutes of Health National Institutes of Health days prior to the meeting due to finalizing
Building 35, Conference Room 620/630, 9000
the agenda and scheduling of meeting topics.
Rockville Pike, Bethesda, MD 20892. National Center for Advancing
Contact Person: Chris Nice, Program (Catalogue of Federal Domestic Assistance
Translational Sciences: Notice of
Assistant, Office of Biotechnology Activities, Program Nos. 93.859, Pharmacology,
Meetings Physiology, and Biological Chemistry
National Institutes of Health, 6705 Rockledge
Drive, Suite 750, Bethesda, MD 20892, 301– Pursuant to section 10(d) of the Research; 93.350, B—Cooperative
496–9838, nicelc@mail.nih.gov. Agreements; 93.859, Biomedical Research
Federal Advisory Committee Act, as and Research Training, National Institutes of
In the interest of security, NIH has amended (5 U.S.C. App.), notice is
instituted stringent procedures for entrance Health, HHS)
hereby given of meetings of the National
onto the NIH campus. All visitor vehicles, Dated: August 13, 2015.
including taxicabs, hotel, and airport shuttles
Center for Advancing Translational
Sciences Advisory Council. Melanie J. Gray,
will be inspected before being allowed on
campus. Visitors will be asked to show one The meetings will be open to the Program Analyst, Office of Federal Advisory
form of identification (for example, a public as indicated below, with Committee Policy.
government-issued photo ID, driver’s license, attendance limited to space available. [FR Doc. 2015–20450 Filed 8–18–15; 8:45 am]
or passport) and to state the purpose of their Individuals who plan to attend and BILLING CODE 4140–01–P
visit. need special assistance, such as sign
Information is also available on the
language interpretation or other
Institute’s/Center’s home page: http:// DEPARTMENT OF HEALTH AND
oba.od.nih.gov/rdna/rdna.html, where an reasonable accommodations, should
notify the Contact Person listed below HUMAN SERVICES
agenda and any additional information for
the meeting will be posted when available. in advance of the meeting.
National Institutes of Health
OMB’s ‘‘Mandatory Information The meetings will be closed to the
Requirements for Federal Assistance Program public in accordance with the Center for Scientific Review; Notice of
Announcements’’ (45 FR 39592, June 11, provisions set forth in sections Closed Meetings
1980) requires a statement concerning the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
official government programs contained in Pursuant to section 10(d) of the
as amended. The grant applications and
the Catalog of Federal Domestic Assistance. Federal Advisory Committee Act, as
Normally NIH lists in its announcements the the discussions could disclose
confidential trade secrets or commercial amended (5 U.S.C. App.), notice is
number and title of affected individual hereby given of the following meetings.
programs for the guidance of the public. property such as patentable material,
and personal information concerning The meetings will be closed to the
Because the guidance in this notice covers
virtually every NIH and Federal research individuals associated with the grant public in accordance with the
program in which DNA recombinant applications, the disclosure of which provisions set forth in sections
molecule techniques could be used, it has would constitute a clearly unwarranted 552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
been determined not to be cost effective or invasion of personal privacy. as amended. The grant applications and
in the public interest to attempt to list these the discussions could disclose
programs. Such a list would likely require Name of Committee: Cures Acceleration confidential trade secrets or commercial
several additional pages. In addition, NIH Network Review Board. property such as patentable material,
could not be certain that every Federal Date: September 3, 2015.
Time: 8 a.m. to 3:15 p.m.
and personal information concerning
program would be included as many Federal
Agenda: Report from the Institute Director. individuals associated with the grant
agencies, as well as private organizations,
both national and international, have elected Place: National Institutes of Health, applications, the disclosure of which
to follow the NIH Guidelines. In lieu of the Building 31, Conference Room 6, 31 Center would constitute a clearly unwarranted
individual program listing, NIH invites Drive, Bethesda, MD 20892. invasion of personal privacy.
readers to direct questions to the information Contact Person: Danilo A. Tagle, Ph.D., Name of Committee: Integrative,
address above about whether individual Executive Secretary, National Center for Functional and Cognitive Neuroscience
programs listed in the Catalog of Federal Advancing Translational Sciences, 1 Integrated Review Group;
Domestic Assistance are affected. Democracy Plaza, Room 992, Bethesda, MD Neuroendocrinology, Neuroimmunology,
(Catalogue of Federal Domestic Assistance 20892, 301–594–8064, Danilo.Tagle@nih.gov. Rhythms and Sleep Study Section.
Program Nos. 93.14, Intramural Research This notice is being published less than 15 Date: October 1–2, 2015.
tkelley on DSK3SPTVN1PROD with NOTICES

Training Award; 93.22, Clinical Research days prior to the meeting due to finalizing Time: 8 a.m. to 6 p.m.
Loan Repayment Program for Individuals the agenda and scheduling of meeting topics. Agenda: To review and evaluate grant
from Disadvantaged Backgrounds; 93.232, Name of Committee: National Center for applications.
Loan Repayment Program for Research Advancing Translational Sciences Advisory Place: Admiral Fell Inn, 888 South
Generally; 93.39, Academic Research Council. Broadway, Baltimore, MD 21231.
Enhancement Award; 93.936, NIH Acquired Date: September 3, 2015. Contact Person: Michael Selmanoff, Ph.D.,
Immunodeficiency Syndrome Research Loan Open: 8 a.m. to 3:15 p.m. Scientific Review Officer, Center for

VerDate Sep<11>2014 19:14 Aug 18, 2015 Jkt 235001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\19AUN1.SGM 19AUN1

Document Created: 2015-12-15 11:59:05
Document Modified: 2015-12-15 11:59:05

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 3, 2015.
FR Citation		80 FR 50300

80 FR 50300 - National Center for Advancing Translational Sciences: Notice of Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 160 (August 19, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health